Abstracts / Cont.
Additional Abstracts
Ramesh, N., Ge, Y., Liu, J., Farson, D., Van Roey, M., Rojas, V., Working, P., Yu, D.C. Demonstration of anti-tumor efficacy with an oncolytic adenovirus CG8840 for the treatment of bladder cancer in an orthotopic tumor model in mice. American Society for Gene Therapy, June 2004.
Ramesh, N., Ge, Y., Van Roey, M., Rojas, G., Liu, J., Farson, D., Working, P. and Yu, D.C. Development of an Orthotopic Bladder Tumor in Mice for Efficacy Studies with a Bladder Tumor Specific Oncolytic Adenovirus CG8840. American Association for Cancer Research. American Association for Cancer Research, March 2004.
Vimal, V., Lin A., and Farson, D. Establishment of GM-CSF Modified Cancer Cell Lines (GVAX) for Large-scale Clinical Trial Production. American Society for Cell Biology (2003).
Farson, D., Tao L., Liu J., Harding T., and Donahue, B. Creation and Characterization of High Titer AAV-Factor IX Producing Clones for Clinical Scale Production. American Society of Gene Therapy (2002).
Vimal, V., Farson, D., Harding, T., and Lin, A. Production of Recombinant Adeno-Associated Viral Vectors (r-AAV) in Suspension Serum-Free Cultures. American Society of Gene Therapy (2002).
Farson, D., Nguyen, H-N., Golds, K., and Veres, G. Lentikat3: Creation and Characterization of High Titer Third Generation Lentivirus Producer Clones in a VSV.G Packaging Cell Line. American Society of Gene Therapy (2002).
Witt, R., McGuinness, R., Liu, J., Dull, T., Kelly, M., Naldini, L., and Farson, D. Lentikat3: A novel third generation, stable packaging cell line for lentivirus production. American Society of Gene Therapy (2001).
Witt, R., Dull, T., Bukovsky, A., Song, J., Radeke, R., Finer, M., Naldini, L., Farson, D. A tet-inducible second generation stable packaging cell line for lentiviral vectors: an advancement in the production of high-titer, safe viral stocks. American Society of Gene Therapy (1999).
Naldini, L., Bukovsky, A., Dull, T., Farson, D., Follenzi, A., Gasmi, M., and Song, J. In vivo performance, manufacturing and assays for third generation lentivirus vectors. American Society of Gene Therapy (1999).
Naldini, L., Dull, T., Song, J.-P., Bukovsky, A, Farson, D., Mandel, R., Zufferey, R., Trono, D., and Kay, M. Development of safe and effective lentiviral vectors. NIH Gene Therapy Policy Conference: Lentiviral Vectors for Gene Delivery (1998).
Naldini, L., Song, J.-P., Kelly, M., Farson, D., Witt, R., Dull, T., Mandel, R., Kay, M., Zufferey, R., and Trono, D. Lentiviral vectors. Keystone Symposium on Gene Therapy Strategies for Hematopoietic Cells (1998).
Farson, D., Dull, T., Limoli, K., McGuinness, R., Lazar, R. and Finer, M. Stable high titer retroviral packaging and producer clones in 293 cells for efficient transduction of human primary lymphocytes. 4th International Conference on Gene Therapy of Cancer (1995).
Finer, M., Dull, T., Cooke, K., Farson, D., Zsebo, K., and Roberts, M. High efficiency supernatant transduction of human hematopoietic cells using retrovirus vectors produced in 293 derived packaging lines. Keystone (1994).
Zsebo, K., Cooke, K., Smith, K, Ruff, D., Dull, T., Farson, D., Roberts, M., and Finer, M. Re-directing the cytotoxic response of neutrophils by high efficiency transduction of stem cells with universal receptor genes. ASH (1994).
Finer, T., Dull, T., Qin, L., Cooke, K., Farson, D., Roberts, M. and Zsebo, K. High efficiency retroviral transduction of chimeric antigen receptors into mouse and human hematopoietic progenitors and primary human lymphocytes. Keystone (1993).
Farson, D., Scott, M., Hlinak, L., Morgan, M., and Kuhn, R. Characterization of human fetal liver cells in culture. American Society for Cell Biology (1990).
Belloni, P., Scott, M., Kuhn, R., and Farson D. Isolation and characterization of human liver sinusoidal endothelial cells: a comparative analysis with hepatocytes. American Society for Cell Biology (1990).
Price, P., Farson, D., Whyte, M.A., and Voss, f. A serum-free medium for the growth and scale-up of CHO cells. International Biotechnology Expo (1988).
Parry, G., Lee, E. Y.-H., Koval, M., Farson, D.A., and Bissell, M.J. Glycosaminoglycan distribution in differentiated mammary epithelial cells: response to culture substrata. J. Cell Biol. 97, 316a (1983).
Hall, H.G., Farson, D.A., Chin, S. and Bissell, M.J. Tissue morphogenesis by epithelial cell lines: collagen overlay induces lumen formation. West Coast Regional Developmental Biology Conference (1983).
Schwarz, R.I., Farson, D.A., Bissell, M.J. and Soo, W.J. Ascorbic acid retards RNA-tumor virus infection of avian cells in culture. American Society for Cell Biology. (1978).
Schwarz, R.I., Farson, D.A., Bissell, M.J. and Soo, W.J. Avian tendon: a new culture system for understanding differentiation and cell-virus interaction. American Society for Cell Biology (1977).
Bissell, M.J. and Farson, D.A. Effect of cell shape on sugar uptake in normal and transformed cells. Proceedings of ICN-UCLA Conferences on Supramolecular Structure: Cell Shape and Surface Architecture, 76 (1976).